Johnson Matthey and Rennovia Announce License Agreement With ADM For Glucaric Acid Technology

News   Feb 24, 2017 | Original Story From Johnson Matthey

 
Johnson Matthey and Rennovia Announce License Agreement With ADM For Glucaric Acid Technology
 
 
 

RELATED ARTICLES

Neuromodulation of Behavior and Individuality Measured Over a Life-Time

News

Researchers illuminate the biology that guides behavior across different stages of life, and also suggest how variations in specific neuromodulators in the developing nervous system may lead to occasional variations.

READ MORE

Stem-Cell Exosome Treatment Repairs Brain Damage Following Stroke

News

A team of researchers have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE